China To Improve Centralized Medicine Procurement Policies

China will refine its centralized drug procurement policy following a probe into off-patent medicine quality concerns. The govt aims to improve pricing mechanisms, enhance quality oversight, and develop a medical insurance catalogue for innovative drugs. Officials dismissed previous quality concerns as unsubstantiated.